Atypical antipsychotics in the treatment of bipolar disorder: Pharmacological and clinical effects

CNS Drugs

Volumn 13, Issue 6, 2000, Pages 433-441

  Dunayevich, Eduardo ^a   McElroy, Susan L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LITHIUM; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

AGRANULOCYTOSIS; ANTICHOLINERGIC EFFECT; BODY WEIGHT DISORDER; CATARACT; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPOTENSION; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MYOCARDITIS; MYOCLONUS; PRIORITY JOURNAL; REVIEW; SCHIZOIDISM; SEDATION; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; TONIC CLONIC SEIZURE; VERTIGO;

EID: 0034093948     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200013060-00005     Document Type: Review

References (90)

1. 1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 199; 51: 8-19
2. 2. Tonen M, Zarate Jr CA. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59 Suppl. 1: 38-48
3. 3. Tollefson GD, Beasley Jr CM, Tamura RN, et al. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997; 154 (9): 1248-54
4. 4. Barnes TR, McPhillips MA. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Int Clin Psychopharmacol 1998; 13 (3 Suppl.): 49-57
5. 5. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45 (9): 789-96
6. 6. Owens JM, Risch SC. Atypical antipsychotics. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Press textbook of psychopharmacology. Washington, DC: The American Psychiatric Press, 1995: 271-3
7. 7. Meltzer HY. Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 1995; 3 (2): 64-75
8. 8. Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry. 1996; 57 Suppl. 11: 4-11
9. 9. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry. 1999; 60 Suppl. 10: 5-14
10. 10. Zarate Jr CA, Tonen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995; 56 (9): 411-7
11. 11. McElroy SL, Dessain EC, Pope Jr HG, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991; 52 (10): 411-4
12. 12. Zarate Jr CA, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995; 56: 108-12
13. 13. Calabrese JR, Kimmel, SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153: 759-64
14. 14. Barbini B, Scherillo P, Benedetti F, et al. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol 1997; 12 (2): 109-12
15. 15. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156 (8): 1164-9
16. 16. Suppes T, McElroy SL, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992; 32 (3): 270-80
17. 17. Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 1991; 11 (6): 396-7
18. 18. Suppes T, Phillips KA, Judd CR. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 1994: 36; 338-40
19. 19. Masi G, Milone A. Clozapine treatment in an adolescent with bipolar disorder. Panminerva Med 1998; 40 (3): 254-7
20. 20. Shulman RW, Singh A, Shulman KI. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol Bull 1997; 33 (1): 113-8
21. 21. Banov MD, Zarate Jr CA, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994; 55 (7): 295-300
22. 22. Kilian JG, Kerr K, Lawrence C, et al. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841-5
23. 23. Peacock L, Gerlach J. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry 1994; 55 (2): 44-9
24. 24. Dwight MM, Keck PE, Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994; 344: 554-5
25. 25. Barkin JS, Pais Jr VM, Gaffney MF. Induction of mania by risperidone resistant to mood stabilizers. Clin Psychopharmacol 1997; 17 (1): 57-8
26. 26. Tomlinson WC. Risperidone and mania. Am J Psychiatry 1996; 153 (1): 132-3
27. 27. O'Croinin F, Zibin T, Holt L. Re: hypomania associated with risperidone [letter]. Can J Psychiatry 1995; 40 (1): 51
28. 28. Sajatovic M, DiGiovanni SK, Bastani B, et al. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacol Bull 1996; 32 (1): 55-61
29. 29. Schnierow BJ, Graeber DA. Manic symptoms associated with initiation of risperidone. Am J Psychiatry 1996; 153 (9): 1235-6
30. 30. Schaffer CB, Schaffer LC. The use of risperidone in the treatment of bipolar disorder [correspondence]. J Clin Psychiatry 1996; 57 (3): 136
31. 31. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995; 56: 423-9
32. 32. Goodnick PJ. Risperidone treatment of refractory acute mania. J Clin Psychiatry 1995; 56 (9): 431-2
33. 33. McIntyre R, Young LT, Hasey G, et al. Risperidone treatment of bipolar disorder. Can J Psychiatry 1997; 42 (1): 88-90
34. 34. Keck PE, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995; 56: 466-70
35. 35. Masand PS, Wang X, Manjooran J, et al. Comparison of risperidone and olanzapine in bipolar and schizoaffective disorders. Presented at: The Meeting of the American College of Psychopharmacology; 1999 Dec 14, Acapulco
36. 36. Tohen M, Zarate Jr CA, Centorrino F, et al. Risperidone in the treatment of mania. J Clin Psychiatry 1996; 57 (6): 249-53
37. 37. Ghaemi SN, Sachs GS, Baldassano CF, et al. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry 1997; 42 (2): 196-9
38. 38. Ghaemi SN, Sachs GS. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol 1997; 12 (6): 333-8
39. 39. Janicak PG, Keck PE, Davis J, et al. Double-blind, randomized study of risperidone vs haloperidol for schizoaffective disorder. Presented at: The Meeting of the American College of Psychopharmacology: 1999 Dec 13; Acapulco
40. 40. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994
41. 41. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21 (3): 176-80
42. 42. Sachs G. Safety and efficacy of risperidone vs placebo vs haloperidol as add-on therapy to mood stabilizers in the treatment of manic phase of bipolar disorder. Presented at: The Meeting of the American College of Psychopharmacology: 1999 Dec 14; Acapulco
43. 43. Vieta E, Gasto C, Colom F, et al. Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol 1998; 18 (2): 172-4
44. 44. Fras I, Major LF. Clinical experience with risperidone [letter). J Am Acad Child Adolesc Psychiatry 1995; 34 (7): 833
45. 45. Frazier JA, Meyer MC, Biederman J, et al. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999; 38 (8): 960-5
46. 46. Singh AN, Catalan J. Risperidone in HIV-related manic psychosis. Lancet 1994; 344: 1029-30
47. 47. Allison DB, Mentone JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156 (11): 1686-96
48. 48. Petty RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999; 35 Suppl.: S67-73
49. 49. Ravindran AV, Jones BW, al-Zaid K, et al. Effective treatment of mania with olanzapine: 2 case reports. J Psychiatry Neurosci 1997; 22 (5): 345-6
50. 50. Weisler RH, Ahearn EP, Davidson JR, et al. Adjunctive use of olanzapine in mood disorders: five case reports. Ann Clin Psychiatry 1997; 9 (4): 259-62
51. 51. Ketter TA, Winsberg ME, DeGolia SG, et al. Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states. J Clin Psychiatry 1998; 59 (2): 83-5
52. 52. Zullino D, Baumann P. Olanzapine for mixed episodes of bipolar disorder [letter]. J Psychopharmacol (Oxf) 1999; 13 (2): 198
53. 53. Soutullo CA, Sorter MT, Foster KD, et al. Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 1999; 53 (3): 279-83
54. 54. Frazier JA, Biederman J, Jacobs TG, et al. Olanzapine in the treatment of bipolar disorder in juveniles. Presented at: The Meeting of the American College of Psychopharmacology: 1999 Dec 13; Acapulco
55. 55. McElroy SL, Frye M, Denicoff K, et al. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord 1998; 49 (2): 119-22
56. 56. Sharma V, Pistor L. Treatment of bipolar mixed state with olanzapine. J Psychiatry Neurosci 1999; 24 (1): 40-4
57. 57. Zarate Jr CA, Narendran R, Tonen M, et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 1998; 59 (1): 24-8
58. 58. Ketter TA, Winsberg ME, Wong PW, et al. Olanzapine in nonpsychotic bipolar disorders. Presented at: The Meeting of the American College of Psychopharmacology: 1999 Dec 14; Acapulco
59. 59. Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999: 14; 339-43
60. 60. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156 (5): 702-9
61. 61. Tohen M, Jacobs TG, Gannon K, et al. Efficacy of olanzapine in the acute treatment of bipolar disorder, with and without psychotic features. Third International Conference on Bipolar Disorder: 1999 Jun 17-19; Pittsburgh (PA)
62. 62. Sanger TM, Tohen M, Jacobs T. Long-term olanzapine treatment of mania: improvement in mood symptoms and cognitive function. Presented at: the American Psychiatric Association 152nd Annual Meeting: 1999 May 15-20; Washington, DC
63. 63. John V, Rapp M, Pies R. Aggression, agitation, and mania with olanzapine [letter]. Can J Psychiatry 1998; 43 (10): 1054
64. 64. Pozo P, Alcantara AG. Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment. J Psychiatry Neurosci 1998; 23 (5): 309-10
65. 65. Lindenmayer JP, Klebanov R. Olanzapine-induced manic-like syndrome. J Clin Psychiatry 1998; 59 (6): 318-9
66. 66. Reeves RR, McBride WA, Brannon GE. Olanzapine-induced mania. J Am Osteopath Assoc 1998; 98 (10): 549-50
67. 67. Ghaemi SN, Katzow JJ. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 1999; 11 (3): 137-40
68. 68. Dunayevich E, Strakowski SM. Quetiapine in treatment-resistant mania: a case report. Am J Psychiatry. In press
69. 69. Sajatovic M, Brescan D, Perez D, et al. Quetiapine in the treatment of neuroleptic-dependent mood disorders. Presented at: the World Psychiatric Association, XI World Congress of Psychiatry: 1999 Aug 6-11; Hamburg, Germany
70. 70. Kane JM. Tardive dyskinesia in affective disorders. J Clin Psychiatry 1999; 60 Suppl. 5: 43-7
71. 71. Haberfellner EM. Tardive dyskinesia during treatment with risperidone. Pharmacopsychiatry 1997; 30 (6): 271
72. 72. Hong KS, Cheong SS, Woo JM, et al. Risperidone-induced tardive dyskinesia [letter]. Am J Psychiatry 1999; 156 (8): 1290
73. 73. Campbell M. Risperidone-induced tardive dyskinesia in first-episode psychotic patients. J Clin Psychopharmacol 1999; 19 (3): 276-7
74. 74. Friedman JH. Rapid onset tardive dyskinesia ('fly catcher tongue') in a neuroleptically naive patient induced by risperidone. Med Health R I 1998; 81 (8): 271-2
75. 75. Carroll NB, Boehm KE, Strickland RT. Chorea and tardive dyskinesia in a patient taking risperidone. J Clin Psychiatry 1995; 56 (10): 484-5
76. 76. Vercueil L, Foucher J. Risperidone-induced tardive dystonia and psychosis [letter]. Lancet 1999; 353 (9157): 981
77. 77. Ghelher D, Belmaker RH. Tardive dyskinesia with quetiapine. Am J Psychiatry 1999; 156 (5): 796-7
78. 78. Herran A, Vazquez-Barquero JL. Tardive dyskinesia associated with olanzapine [letter]. Ann Intern Med 1999; 131 (1): 72
79. 79. Dunayevich E, Strakowski SM. Olanzapine-induced tardive dystonia [letter]. Am J Psychiatry 1999; 156 (10): 1662
80. 80. Bruneau MA, Stip E. Metronome or alternating Pisa syndrome: a form of tardive dystonia under clozapine treatment. Int Clin Psychopharmacol 1998; 13 (5): 229-32
81. 81. Karp BI, Goldstein SR, Chen R, et al. An open trial of clozapine for dystonia. Mov Disord 1999; 14 (4): 652-7
82. 82. Meltzer HY, Luchins DJ. Effect of clozapine in severe tardive dyskinesia: a case report. J Clin Psychopharmacol 1984; 4 (5): 286-7
83. 83. Levkovitch Y, Kronenberg J, Kayser N, et al. Clozapine for tardive dyskinesia in adolescents. Brain Dev 1995; 17 (3): 213-5
84. 84. Chong SA, Remington G, Tan CH. Risperidone treatment of tardive dyskinesia and dystonia. J Clin Psychiatry 1999; 60 (5): 340-1
85. 85. Koponen HJ. Risperidone in the treatment of psychosis and concomitant buccolinguomasticatory dyskinesia in the elderly. Int J Geriatr Psychiatry 1997; 12 (3): 412-3
86. 86. Soutullo CA, Keck Jr PE, McElroy SL. Olanzapine in the treatment of tardive dyskinesia: a report of two cases. J Clin Psy-chopharmacol 1999; 19 (1): 100-1
87. 87. Littrell KH, Johnson CG, Littrell S, et al. Marked reduction of tardive dyskinesia with olanzapine. Arch Gen Psychiatry 1998; 55 (3): 279-80
88. 88. Almeida OP. Olanzapine for the treatment of tardive dyskinesia. J Clin Psychiatry. 1998; 59 (7): 380-1
89. 89. Rothschild AJ, Bates KS, Boehringer KL, et al. Olanzapine response in psychotic depression. J Clin Psychiatry 1999; 60 (2): 116-8
90. 90. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - a functional approach. Pharmacopsychiatry 1992; 25: 213-7